Comparing Outcomes of Trabeculectomy with Mitomycin C to 45-μm Gelatin Stent Placed Ab Externo with Open Conjunctiva
Ophthalmology Glaucoma · 2024
DOI: 10.1016/j.ogla.2023.11.005 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Ophthalmology Glaucoma, 2024. Verfasst von Ernesto Sabogal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Massachusetts Eye and Ear, Glaucoma Service, Boston, Massachusetts. Hauptthemen laut MEDLINE: Mitomycin, Trabeculectomy, Intraocular Pressure, Stents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
PURPOSE: To compare trabeculectomy with mitomycin C (trab-MMC) and XEN45 Gel Stent placed ab externo with open conjunctiva (XGS AEO) with or without cataract surgery in patients with glaucoma. DESIGN: Nonrandomized, retrospective, comparative study. SUBJECTS: A total of 204 eyes from 204 glaucoma patients who received XGS AEO or underwent trab-MMC with or without cataract surgery between July 2018 and August 2021 at Massachusetts Eye and Ear. METHODS: Visits from 204 patient charts were reviewed after either trab-MMC or XGS AEO from 2018 to 2021 from a level 3 triage center. MAIN OUTCOME MEASURES: Intraocular pressure (IOP), medication burden, Kaplan-Meier success rates, 5-fluorouracil impact, and complications. RESULTS: One hundred fifty-seven patients underwent trab-MMC and 47 underwent XGS AEO. Groups had similar baseline intraocular pressure (IOP) and medications (meds). Intraocular pressure and meds decreased similarly at 1.5 years (11.2 mmHg vs. 7.4 mmHg, P = 0.62; 2.9 vs. 2.8 meds, P = 0.92, respectively for trab-MMC and XGS AEO). Success was defined as IOP reduction ≥ 20% with 5 mmHg ≤ IOP ≤ 18 mmHg for 2 consecutive visits. Complete success (CS) did not allow meds; qualified success (QS) allowed for ≤ baseline meds. When IOP fluctuations in the first 60 days were not counted as failures, CS was 43% for trab-MMC, about 8.5% higher than for XGS AEO (P < 0.01). Qualified success was similar between the groups (65%-67%). Procedure time was shorter for XGS AEO than trab-MMC (44 vs. 63 minutes, P < 0.01). CONCLUSIONS: XEN45 Gel Stent AEO may provide similar benefits to trab-MMC, especially for patients who tolerate some meds, with shorter procedure times. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Massachusetts Eye and Ear, Glaucoma Service, Boston, Massachusetts.
- Department of Ophthalmology, Massachusetts Eye and Ear, Glaucoma Service, Boston, Massachusetts. Electronic address: david_sola-delvalle@meei.harvard.edu.
Zitieren
APA
Sabogal, E., Ingram, Z., Odishelidze, N., El Helwe, H., Falah, H. K., Trzcinski, J., Hall, N., & Solá-Del Valle, D. (2024). Comparing Outcomes of Trabeculectomy with Mitomycin C to 45-μm Gelatin Stent Placed Ab Externo with Open Conjunctiva. Ophthalmology Glaucoma. https://doi.org/10.1016/j.ogla.2023.11.005
Vancouver
Sabogal E, Ingram Z, Odishelidze N, El Helwe H, Falah HK, Trzcinski J, et al. Comparing Outcomes of Trabeculectomy with Mitomycin C to 45-μm Gelatin Stent Placed Ab Externo with Open Conjunctiva. Ophthalmology Glaucoma. 2024. doi:10.1016/j.ogla.2023.11.005
BibTeX
@article{Sabogal2024,
author = {Sabogal, Ernesto and Ingram, Zoë and Odishelidze, Nino and El Helwe, Hani and Falah, Henisk K and Trzcinski, Jonathan and Hall, Nathan and Solá-Del Valle, David},
title = {Comparing Outcomes of Trabeculectomy with Mitomycin C to 45-μm Gelatin Stent Placed Ab Externo with Open Conjunctiva},
journal = {Ophthalmology Glaucoma},
year = {2024},
doi = {10.1016/j.ogla.2023.11.005}
}
EUVIMED